C. D. Jones

发表

Case Histories Of Drill Stem Testing As A Part Of An Effective Formation Evaluation Program

C. D. Jones, 1966 .

Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.

H W Cole, C. D. Jones, K. Matsumoto, 1997, Journal of medicinal chemistry.

Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers

C. D. Jones, K. Desante, R. Bowsher, 1994, Antimicrobial Agents and Chemotherapy.

The in vitro anti-hepatitis B virus activity of FIAU [1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell.

C. D. Jones, J. Colacino, K. Staschke, 1994, Antiviral research.

Non-steroidal Estrogens

C. D. Jones, J. Dodge, C. Jones, 1999 .

Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels.

Charles David Jones, C. D. Jones, J. Clemens, 1983, Life sciences.

LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.

C. D. Jones, D. Russell, N. Stamm, 1993, Proceedings of the National Academy of Sciences of the United States of America.

LY191704 inhibits type I steroid 5 alpha-reductase in human scalp.

C. D. Jones, D. Tindall, B. Neubauer, 1996, The Journal of clinical endocrinology and metabolism.

Antagonism of estrogen action with a new benzothiophene derived antiestrogen.

C. D. Jones, J. Falcone, L. Black, 1983, Life sciences.

Molecular determinants of tissue selectivity in estrogen receptor modulators.

C. D. Jones, K. Matsumoto, J. Dodge, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Human Toll-Like Receptor 8-Selective Agonistic Activities in 1-Alkyl-1H-benzimidazol-2-amines

C. D. Jones, A. Dixit, M. Beesu, 2014, Journal of medicinal chemistry.

Aromatase inhibition by 5-substituted pyrimidines and dihydropyrimidines.

C. D. Jones, K. S. Hirsch, J. Davenport, 1987, Journal of medicinal chemistry.

Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal in

C. D. Jones, A. Pike, M. Jevnikar, 1984, Journal of medicinal chemistry.

Regioselectivity in the Alkaline Thiolate Deprotection of Aryl Methyl Ethers

C. D. Jones, J. Dodge, M. Stocksdale, 1995 .

Some applications of rates of methiodide formation to alkaloid structural determination

C. D. Jones, M. Shamma, J. A. Weiss, 1969 .

LY 191704 : A selective , nonsteroidal inhibitor of human steroid 5 a-reductase type 1 ( 5 a-reductase / dihydrotestosterone / benzoquinolinone / benign prostatic hyperplasia )

C. D. Jones, D. Russell, N. Stamm, 2005 .